We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.125 | 17.75 | 18.50 | 18.125 | 18.125 | 18.13 | 34,129 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.38 | 16.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/9/2017 21:27 | I certainly would not pay. I do my own research and dont need his / their self fulfilling prophesies Apologies for off topic. But felt the need to input | zebbo | |
10/9/2017 19:59 | I think there will be loads paying !!! ??. Plenty of mug punters on that site.... | bobdown2 | |
10/9/2017 18:59 | O/T I see blogger TW wants peeps to pay £72 p/a to access Shareprophets. Not sure many will feel its worth paying for his opinionated rantings. | someuwin | |
10/9/2017 18:32 | Coverage of this week's Tata deal in 'Food Navigator Asia': Tata and OptiBiotix seal deal for India prebiotic expansion By Gary Scattergood+, 11-Sep-2017 OptiBiotix Health has signed a scale-up and manufacturing deal with Tata Chemicals' Food and Nutrition division in India for its cholesterol-reducing prebiotic, LPGOS. | parob | |
10/9/2017 16:30 | Email to Max way back in November. Self explanatory. Hi Max, Follow on from my earlier email. I was given permission to use our corporate email address (xxxxxxx) for a simple survey a couple of weeks ago. I also used my FB friends as well. The question format was simple and designed for a rapid response, lest it got ignored. Question; favorite milk shake flavours and favourate snack bar flavour (350+ replies). I got a very good response, which took nearly 2 days to sort. I may get a few more later but I think I have a good grasp of what most people like. I dare say there are very few surprises for you. Shake flavours top 10 1 Oreo cookie 2 Chocolate 3 Vanilla 4 Strawberry 5 Banana 6 Marshmallow 7 Caramel 8 Coconut 9 Choco mint 10 Coal - I think someone may be pregnant I see a number of the above making great combinations as well. Snack bars 1 Fruit & nut 2 cashew 3 Peanut butter 4 Oaty 5 Chocolate brownie (I expected this be No1) 6 Cherry & Almonds (never occurred to me) 7 Yoghurt 8 Cappiccino | elrico | |
10/9/2017 16:18 | Wow....five compelling flavours....looks like something out of an ice cream parlour... | bobdown2 | |
10/9/2017 15:36 | Where did you see that Elric? | deeppockets | |
10/9/2017 15:30 | NEW flavours!Sorry about the radio silence on new products and flavours. We have been developing an improved shake formula and testing a high tech agglomeration technique for our shakes. The great news is the the new generation of shakes will mix easily with water. We need YOUR HELP to choose the new shake flavours. Please just reply to this post with your top flavour/s:1. Mixed berry (raspberry and strawberry)2. Hazelnut3. Cookies and Cream4. Cacao mint5. Vanilla cappuccino ...... or tell us your favourite and we will try it ourselves.As a thank you we have a 20% off voucher for you - enter code THANKS20 at checkout. We will also send you a free shaker with your order.Thank you!Max and Filipa | elrico | |
10/9/2017 10:40 | Neurologist Speaks Out About the Importance of Gut Health for Prevention and Treatment of “Incurable&rdq extract; They manufacture important vitamins that are important to keep your brain healthy. They also maintain the integrity of the lining of your gut,” he explains. The latter is important because when your gut lining becomes compromised, you end up with permeability or leakiness of the gut. This increases inflammation, which is a cornerstone of virtually all brain disorders, from Alzheimer’s and multiple sclerosis (MS), to Parkinson’s and autism. “We’ve got to really deal with it on a preventive basis,” Dr. Perlmutter says. “[We must] understand what in our Western culture, especially from a dietary perspective, is threatening the health of our commensals. We call these bacteria ‘commensals&rs | elrico | |
09/9/2017 23:52 | TATA - Food and Nutrition We have introduced a range of nutritional solutions under the brand name SustentialsTM. Sustentials offers innovative nutritional ingredients like prebiotics, oligosaccharides and polyols which help ensure both taste and health in modern foods. TCL's nutritional solutions business caters to food, beverage, nutra and pharma industry and has various products within the brand. Under the Nutraceutical portfolio, the company offers nature-sourced, science and tech backed ingredients and formulations with specific health benefits. Tata chemicals to build on food business (re Tata's Yale University collaboration): Tata Chemicals is building a food business keeping health as its focus especially when the definition of what constitutes healthy food keeps changing. It is trying to build a business around the microbiome, the scientific name for the complete set of microorganisms living in our bodies. The discovery of the role of microorganisms in disease has uncovered an entirely new field that is growing in sophistication every day, and providing clues to what really happens in our bodies. Tata Chemicals started a project to understand the role of gut bacteria in health and disease, and specifically on the role of prebiotics and gut bacteria and physiology. The company’s larger goal is to transition dietary supplements from a poorly-understood field to a true understanding of the mechanisms by which they have their effects. FOS and GOS are sometimes called prebiotics, and are becoming a popular form of dietary supplement. ------------ ALL IMO - in the same way OPTI will help Sacco crack the US market with LP-LDL, they will help Tata expand their healthy food business with Slimbiome and LPGOS - (hopefully LP-LDL and Sweetbiotix in the future) - by offering science-backed product differentiation. Again a win win situation for all parties. No wonder both Sacco and Tata wanted exclusivity. | parob | |
09/9/2017 13:55 | Parob....I'm a having a very busy period.....I knew that there was something I had forgotten. And your last post could be spot on.. And if it is only one or two batches then the share price will move up very quickly after the trades have finished..quality post...thanks. | bobdown2 | |
09/9/2017 13:19 | There is the possibility that YSF have sold 300K to an institution.In the early summer SOH said this about them (post 24143):"As a regional investment fund its reason d'aitre is to support new investments and occasionally it has to sell shares to allow it to reinvest or to bid for external funds. We are fortunate that our institutional investors are very supportive of OptiBiotix and when there is a need to sell shares rather than put them on the market they will often approach us first. This allows OptiBiotix to place shares with interested institutional investors who are looking for large amounts of shares but are unlikely to buy small amounts in the market. With a large volume this is often at a market discount which temporarily affects the share price."And wasn't the dip well bought into. Look at the buys that went through Friday pm at 74.5p.The last notification of YSF selling was back in May. | parob | |
09/9/2017 12:25 | SHARE PUNT OF THE WEEK: Venture Life makes healthcare and cosmetic products for the over-40s By City & Finance Reporter for the Daily Mail Published: 21:51, 8 September 2017 | Updated: 21:51, 8 September 2017 What is it? Venture Life makes healthcare and cosmetic products for the over-40s. These include food supplements for lowering cholesterol and maintaining brain function, anti-ageing creams, eye treatments and devices to ease conditions such as haemorrhoids. What's the latest? On Thursday, shares surged 1 per cent after two key updates were announced. Firstly, it has partnered with a European pharmaceutical sales firm to market and sell its popular mouthwash UltraDEX in Italy from early next year. It also announced the first group of long-term distribution agreements for its fungal nail treatment Myco-Clear. The updates come hot on the heels of Venture's trading update for the first half of the year that revealed a 28 per cent jump in year-on-year revenues to £7.8million. Who backs it? Manufacturing director Gianluca Braguti is the biggest shareholder with 19.2 per cent. Chief executive and co-founder Jerry Randall owns 10.7 per cent. Why should you invest? A number of positive developments across its product range in recent months is a good sign. It has also secured entry into the massive Chinese market, as well as growing in Europe. Products are still being rolled out at a relatively slow pace, but as this picks up it could be worth being part of the ride. And why you shouldn't. Venture Life is a very small player, and some investors may want more scale and evidence of success before buying shares. | dire cons | |
09/9/2017 10:09 | Shrewd, No prob Have a nice weekend | judijudi | |
09/9/2017 09:43 | Judi If we have an ii getting on board then 300k won't be anywhere near what they are after. Admittedly it's a decent chunk and quite possibly part of Evans holding including the options. Apologies if you feel I was misleading. S | shrewdmole | |
09/9/2017 09:22 | shrewd, "They may get a few thousand here and there" Somebody dumped at least 300,000 yesterday That's not a few thou here n there Let's hope they've finished coz if not we stay range bound I'm fully loaded and in for the long term but your post is inaccurate and mis-leading 300,000 is a chunky volume to sell imho | judijudi | |
09/9/2017 08:44 | HLH have recently made a video for Lactobact LP-LDL Control (INTERVIEW MIT DR. JÜTTNER) - appears on YouTube and the product page on their own site. It's obviously in German, but the animation and graph showing cholesterol reduction across age groups towards the end is worth a look: ---------------- LP-LDL now has its own Twitter page which looks to have been set up in the past couple of days. Here's the address: @LPLDL1 Per Rehne also joined Twitter this past week: @PerPrehne I presume these accounts have been set up in advance of expected news flow which should give them plenty to tweet about over the coming months! | parob | |
09/9/2017 08:36 | Wait a bit, folks. I need another 100k before she blows. | aspex | |
09/9/2017 00:17 | Guys for a few days it's been obvious we have a major order being filled. It's not wishful thinking or a conspiracy. Constant actual bid prices for several times normal market size at above mid is about as big a sign as you can wish for. And now we will get the dip to shake the weak. Problem they have and we all said it is that Opti has a core of holders that know what's coming. So they may get a few thousand here and there but to get serious volume it would have to be 150p+ for me to even think about it and even then I think it's cheap. £5+ in 2 years or sooner. Way before profit support it but that's how the market works. | shrewdmole | |
08/9/2017 20:10 | 773 what are you on about, the more buying is not an automatic, when the mms are consolidating, they will drive the price down to balance their books. Understanding what is happening is key to how you buy and trade. Your buy small sell big! Well if it was that easy we would not find it so difficult. | bobdown2 | |
08/9/2017 19:05 | What the xxxxxooooooo are you on about people buy people sell the more buyers the price goes up People who bought in the 50s will be making a v e ryder nice profit Up and down it will be like this even when we get to 100 + Buy small sell big | tony773 | |
08/9/2017 18:21 | It is a shame about that sell because with all those buys we would have been a few pence higher....let see what sort of trading appears at the start of next week. | bobdown2 | |
08/9/2017 16:41 | How do you know they/he have finished? | judijudi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions